Persistence on treatment and blood pressure control with different first-line antihypertensive treatments: a

Maria Grazia Prandin1, Arrigo F G Cicero, Maddalena Veronesi

  • 1D. Campanacci Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy.

Insights

Angiotensin receptor blockers (ARBs) and ACE inhibitors showed higher treatment persistence in hypertensive patients compared to other drug classes. Lercanidipine also improved persistence among calcium channel blockers.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Management

Background:

  • Hypertension treatment adherence is crucial for long-term cardiovascular health.
  • Comparing first-line antihypertensive drug classes is essential for optimizing patient outcomes.

Purpose of the Study:

  • To evaluate treatment persistence and blood pressure reduction across different first-line antihypertensive drug classes.
  • To compare the efficacy of specific agents within drug classes, such as lercanidipine versus other calcium channel blockers.

Main Methods:

  • A 24-month follow-up study involving 347 hypertensive patients.
  • Random allocation to various first-line antihypertensive treatments.
  • Analysis of treatment persistence rates and blood pressure changes.

Main Results:

  • Higher persistence was observed with Angiotensin Receptor Blockers (ARBs) (68.5%) and ACE inhibitors (64.5%) compared to CCBs (51.6%), beta-blockers (44.8%), and diuretics (34.4%).
  • Lercanidipine demonstrated superior persistence (59.3%) versus other CCBs (46.6%).
  • Greater blood pressure reduction was achieved with ARBs (-11.2/-5.8 mmHg), ACE inhibitors (-10.5/-5.1 mmHg), and CCBs (-8.5/-4.6 mmHg) than with beta-blockers (-4.0/-2.3 mmHg) and diuretics (-2.3/-2.1 mmHg).

Conclusions:

  • ARBs and ACE inhibitors are associated with superior treatment persistence in hypertension management.
  • Lercanidipine offers improved persistence within the CCB class.
  • These findings support the use of ARBs and ACE inhibitors for better adherence and blood pressure control in hypertensive patients.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...